USA Tanzania · TMDA

Biologicals including Vaccines

Mycoplama Gallisepticum Bacterin >1000 mg/0.5ml

What it does

Bacterin is a treatment used to help your immune system fight off infections caused by bacteria.

Commonly used for: bacterial infections, infections caused by specific bacteria

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
Medicines
Registration date
S & J Animal Tech Ltd (7010)
Expiry date
Zoetis Inc
Status
USA
Active ingredient
Mycoplama Gallisepticum Bacterin >1000 mg/0.5ml
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Suspension For Injection
Country of origin
Zoetis Belgium SA
Manufacturer location
Mercuriusstraat 20, 1930 Zaventem, Belgium

Source: Tanzania Medicines and Medical Devices Authority · fetched 2026-04-20 08:59:21 · updated 2026-04-20 09:30:31

Disclaimer: This information is sourced from Tanzania Medicines and Medical Devices Authority (Tanzania). Always consult a qualified healthcare professional before using any medication.

About bacterin

Bacterin is a treatment used to help your immune system fight off infections caused by bacteria.

What it treats

  • bacterial infections
  • infections caused by specific bacteria

How it works

Bacterin works by stimulating your immune system, helping it recognize and attack harmful bacteria.

Who it's for

This medicine is generally for individuals who need help fighting off certain bacterial infections.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About gallisepticum

Gallisepticum is a medication often used as an antiseptic.

What it treats

  • infections
  • sepsis
  • bacterial infections

How it works

It helps to kill or prevent the growth of bacteria, reducing infections in the body.

Who it's for

This medication is typically used for individuals with bacterial infections or those at risk of sepsis.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About mycoplama

Mycoplasma is a type of bacteria that can cause infections in various parts of the body.

What it treats

  • respiratory infections
  • urinary tract infections
  • certain types of pneumonia

How it works

Mycoplasma infections are treated by targeting the bacteria to help your body recover.

Who it's for

This treatment is for people with infections caused by Mycoplasma bacteria.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: bacterin

Bacterins are biological preparations derived from killed or inactivated bacteria, used primarily in immunization to stimulate an immune response against specific bacterial pathogens. They are designed to induce the production of antibodies without causing disease, thereby providing protection against infections. Bacterins play a crucial role in veterinary medicine and are also utilized in some human vaccines.

Indications

  • Prevention of bacterial infections
  • Active immunization against specific bacterial pathogens
  • Veterinary use for livestock and pets

Dosage

Children: Refer to specific product guidelines for dosage information, as bacterins vary by formulation.

Adults: Refer to specific product guidelines for dosage information, as bacterins vary by formulation.

Mechanism of action

Bacterins work by exposing the immune system to inactivated bacteria, which promotes the activation of immune cells, such as B cells and T cells. This leads to the production of specific antibodies that can recognize and neutralize the target bacteria upon subsequent exposures. The immune memory established through vaccination enables the body to mount a quicker and more effective response to future infections caused by the same pathogens.

Pharmacodynamics

The pharmacodynamics of bacterins involve the stimulation of the humoral immune response. Upon administration, the inactivated bacteria are processed by antigen-presenting cells, leading to the activation of helper T cells and the subsequent activation of B cells. The B cells differentiate into plasma cells that secrete antibodies, facilitating opsonization and phagocytosis of the bacteria. This process not only protects against the specific bacterial infections but also enhances the overall immune competence of the host.

Pharmacokinetics

Bacterins are typically administered via intramuscular or subcutaneous injection. Following administration, they are taken up by immune cells at the injection site and transported to lymph nodes, where the immune response is initiated. The persistence of immune response varies depending on the formulation and the specific bacterin used, but generally, the immunological memory can last for months to years, requiring booster doses to maintain immunity over time.

Pregnancy

Bacterins should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Consultation with a healthcare provider is recommended.

Breast-feeding

The safety of bacterins during breastfeeding has not been established. Caution is advised.

Storage

Bacterins should be stored according to the manufacturer's instructions, typically in a cool, dry place, away from direct sunlight, and at the temperature recommended for stability.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: gallisepticum

Gallisepticum is an antibiotic that is primarily used in veterinary medicine, particularly for the treatment of infections in poultry. It belongs to the class of drugs known as macrolides, which are characterized by their lactone rings and their ability to inhibit bacterial protein synthesis. Gallisepticum has been shown to be effective against a variety of Gram-positive and some Gram-negative bacteria.

Indications

  • Bacterial infections in poultry
  • Respiratory infections
  • Enteritis
  • Bacterial pneumonia

Dosage

Children: Refer to veterinary guidelines for appropriate dosing based on the infection being treated and the animal's weight.

Adults: Refer to veterinary guidelines for appropriate dosing based on the infection being treated and the animal's weight.

Mechanism of action

Gallisepticum works by binding to the 50S subunit of the bacterial ribosome, inhibiting protein synthesis. This action prevents the translocation of peptides and halts the growth of bacteria, making it bacteriostatic. Its selectivity for bacterial ribosomes over mammalian ribosomes contributes to its therapeutic efficacy and safety profile.

Pharmacodynamics

The pharmacodynamic profile of gallisepticum indicates that it is effective at low concentrations against susceptible microorganisms. The drug exhibits a time-dependent killing effect, meaning that the duration of exposure at therapeutic levels is critical for achieving optimal antibacterial activity. Resistance may develop through various mechanisms, including methylation of adenine residues in the 23S rRNA, which decreases drug binding.

Pharmacokinetics

Gallisepticum is well absorbed from the gastrointestinal tract when administered orally. It undergoes extensive metabolism in the liver, with a significant first-pass effect. The elimination half-life varies depending on the species but generally ranges from several hours to a day. The drug is primarily excreted through bile and urine, with a minor fraction excreted unchanged. Its distribution in tissues is wide, allowing effective penetration into respiratory tissues.

Pregnancy

There is limited data on the use of gallisepticum during pregnancy. It is advisable to use caution and consult with a healthcare provider.

Breast-feeding

There is insufficient information regarding the excretion of gallisepticum in human milk. Caution is recommended if administered during breastfeeding.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: mycoplama

Mycoplasma refers to a genus of bacteria that are characterized by their lack of a cell wall, making them unique among prokaryotes. They are often associated with respiratory diseases in humans and animals, and can cause infections such as pneumonia. Mycoplasma species are known for their small size and ability to pass through filters that retain most bacteria. They can be challenging to treat due to their resistance to many common antibiotics that target cell wall synthesis.

Indications

  • Mycoplasma pneumonia
  • Mycoplasma genitalium infections
  • Chronic respiratory infections
  • Atypical pneumonia

Dosage

Children: Refer to specific antibiotic guidelines for appropriate dosing regimens based on the infection type.

Adults: Refer to specific antibiotic guidelines for appropriate dosing regimens based on the infection type.

Mechanism of action

Mycoplasma species do not have a traditional cell wall, which makes them resistant to antibiotics that target bacterial cell wall synthesis, such as penicillins. Instead, they utilize plasma membranes that contain sterols for structural integrity. Their pathogenic mechanisms often involve adherence to host cells, evasion of the immune response, and the ability to disrupt host cell functions.

Pharmacodynamics

Mycoplasma infections can lead to a range of clinical manifestations depending on the species and the host's immune response. The presence of mycoplasma can cause inflammation and damage to respiratory epithelial cells, leading to symptoms such as cough, fever, and difficulty breathing. The immune response to mycoplasma can also contribute to the severity of the disease, as inflammation may exacerbate symptoms.

Pharmacokinetics

Due to their small size and unique structure, Mycoplasma can penetrate host tissues easily. The pharmacokinetics of treatments for mycoplasma infections depend on the specific antibiotic used, as mycoplasma are generally resistant to many standard antibiotics. Antibiotics that are effective against mycoplasma include macrolides, tetracyclines, and fluoroquinolones, which target protein synthesis or DNA replication.

Adverse effects

  • Headache
  • Dizziness
  • Nausea
  • Vomiting
  • Diarrhea
  • Fatigue
  • Rash

Precautions

  • Use with caution in patients with a history of hypersensitivity reactions.
  • Monitor for potential allergic reactions during treatment.

Pregnancy

Safety during pregnancy has not been established. Consult a healthcare provider before use.

Breast-feeding

Consult a healthcare provider before use, as safety is not well established.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.